Skip to main content

Articles

459 result(s) for 'alliance clinical trials' within Trials

Page 4 of 10

  1. Binge eating disorder (BED) is a prevalent clinical eating disorder associated with increased psychopathology, psychiatric comorbidity, overweight and obesity, and increased health care costs. Since its inclus...

    Authors: Martina de Zwaan, Stephan Herpertz, Stephan Zipfel, Brunna Tuschen-Caffier, Hans-Christoph Friederich, Frauke Schmidt, Olaf Gefeller, Andreas Mayr, Tony Lam, Carmen Schade-Brittinger and Anja Hilbert
    Citation: Trials 2012 13:220
  2. Cognitive biases play an important role in the development and maintenance of emotional disorders, such as depression and anxiety. Novel procedures, known as Cognitive Bias Modification (CBM), aim to reduce th...

    Authors: Inés Nieto and Carmelo Vazquez
    Citation: Trials 2021 22:510
  3. Recently, we demonstrated that the Montreal Museum of Fine Arts’ (MMFA) participatory art-based activity, known as “Thursdays at the Museum,” improved the well-being, quality of life, and physical health (i.e....

    Authors: Olivier Beauchet, Liam Cooper-Brown, Yoko Hayashi, Kevin Galery, Christine Vilcocq and Thomas Bastien
    Citation: Trials 2020 21:709
  4. In the last few years, excessive internet use and computer gaming have increased dramatically. Salience, mood modification, tolerance, withdrawal symptoms, conflict, and relapse have been defined as diagnostic...

    Authors: Susanne Jäger, Kai W Müller, Christian Ruckes, Tobias Wittig, Anil Batra, Michael Musalek, Karl Mann, Klaus Wölfling and Manfred E Beutel
    Citation: Trials 2012 13:43
  5. Over the last 20 years, there have been marked improvements in the availability of effective medications for rheumatic conditions such as gout, osteoporosis and rheumatoid arthritis (RA), which have led to a r...

    Authors: Ayano Kelly, Allison Tong, Kathleen Tymms, Lyn March, Jonathan C. Craig, Mary De Vera, Vicki Evans, Geraldine Hassett, Karine Toupin-April, Bart van den Bemt, Armando Teixeira-Pinto, Rieke Alten, Susan J. Bartlett, Willemina Campbell, Therese Dawson, Michael Gill…
    Citation: Trials 2018 19:204
  6. Placebo effects are a well-established phenomenon in the treatment of depression. However, the mechanism underlying these effects are not fully understood. Treatment expectations are considered one explanation...

    Authors: Liv Henrich, Marcel Wilhelm, Philipp Lange and Winfried Rief
    Citation: Trials 2023 24:540
  7. Depression and anxiety impact up to 1 in 5 pregnant and postpartum women worldwide. Yet, as few as 20% of these women are treated with frontline interventions such as evidence-based psychological treatments. M...

    Authors: D. R. Singla, S. E. Meltzer-Brody, R. K. Silver, S. N. Vigod, J. J. Kim, L. M. La Porte, P. Ravitz, C. E. Schiller, N. Schoueri-Mychasiw, S. D. Hollon, A. Kiss, D. Clark, A. K. Dalfen, S. Dimidjian, B. N. Gaynes, S. R. Katz…
    Citation: Trials 2021 22:186
  8. Self-harm is common in the community with a lifetime prevalence of 13 %. It is associated with an elevated risk of overall mortality and suicide. People who harm themselves are high users of public services. E...

    Authors: Alexandra Wright-Hughes, Elizabeth Graham, Amanda Farrin, Michelle Collinson, Paula Boston, Ivan Eisler, Sarah Fortune, Jonathan Green, Allan House, David Owens, Mima Simic, Sandy Tubeuf, Jane Nixon, Christopher McCabe, Michael Kerfoot and David Cottrell
    Citation: Trials 2015 16:501
  9. Visual or visual-and-intellectual disabilities of children make daily interactions more difficult for their parents and may impact the quality of the parent-child relationship. To support these parents, an exi...

    Authors: Mathilde M. Overbeek, Paula S. Sterkenburg, Sabina Kef and Carlo Schuengel
    Citation: Trials 2015 16:401
  10. Health education is one of the main items to enable health promotion to patients with fibromyalgia. The objective of the study “Amigos de Fibro (Fibro Friends)” is to evaluate the impact of an educational inte...

    Authors: Mateus Dias Antunes, Felipe Cayres Nogueira da Rocha Loures, Ingred Merllin Batista de Souza, Ariela Torres Cruz, Priscila de Oliveira Januário, Mara Maria Lisboa Santana Pinheiro, Ana Carolina Basso Schmitt, Elisa Frutos-Bernal, Ana María Martín-Nogueras and Amélia Pasqual Marques
    Citation: Trials 2023 24:655
  11. Norwegian health, care, and welfare services are experiencing increased demands to deliver services that are safe, effective, of high quality, and that ensure user involvement. Yet, evidence-based treatment fo...

    Authors: Kristine Amlund Hagen, Asgeir Røyrhus Olseth, Hanne Laland, Kristian Rognstad, Anett Apeland, Elisabeth Askeland, Knut Taraldsen, Bernadette Christensen, John Kjøbli, Ana M. Ugueto, Sarah Kate Bearman and John Weisz
    Citation: Trials 2019 20:16
  12. After the birth of a child, many mothers and fathers experience postpartum mental disorders like depression, anxiety, obsessive-compulsive disorder, stress or other illnesses. This endangers the establishment ...

    Authors: J. Mattheß, M. Eckert, K. Richter, G. Koch, T. Reinhold, P. Vienhues, A. Berghöfer, S. Roll, T. Keil, F. Schlensog-Schuster, K. von Klitzing, C. Ludwig-Körner and L. Kuchinke
    Citation: Trials 2020 21:490
  13. Multiple sclerosis (MS) is an unpredictable, chronic neurological disease accompanied with high rates of depression and anxiety, particularly in the early stages of diagnosis. There is evidence to suggest that...

    Authors: Litza Kiropoulos, Trevor Kilpatrick, Tomas Kalincek, Leonid Cherulov, Elizabeth McDonald, Tissa Wijeratne, Jennifer Threader, Vanja Rozenblat, Neil Simpson-O’Brien, Anneke Van Der Walt and Lisa Taylor
    Citation: Trials 2020 21:100

    The Correction to this article has been published in Trials 2020 21:284

  14. Trial research has predominantly focused on patient and staff understandings of trial concepts and/or motivations for taking part, rather than why treatment recommendations may or may not be followed during tr...

    Authors: Julia Lawton, Nicholas Jenkins, Julie L Darbyshire, Rury R Holman, Andrew J Farmer and Nina Hallowell
    Citation: Trials 2011 12:108
  15. Most people with mental disorders, including those with severe and chronic disorders, are treated solely by their general practitioner (GP). Nevertheless, specialised mental health care may be required for spe...

    Authors: Markus W. Haun, Justus Tönnies, Regina Krisam, Dorothea Kronsteiner, Michel Wensing, Joachim Szecsenyi, Markus Vomhof, Andrea Icks, Beate Wild, Mechthild Hartmann and Hans-Christoph Friederich
    Citation: Trials 2021 22:327
  16. Borderline personality disorder (BPD) is a high prevalence and serious mental health disorder that has historically challenged the finite resources of health services. Despite empirical evidence supporting str...

    Authors: Judy A. Pickard, Adam Finch, Elizabeth Huxley, Michelle L. Townsend, Stephanie Deuchar, Kate L. Lewis, Jason Pratt and Brin F. S. Grenyer
    Citation: Trials 2021 22:383
  17. We aimed to evaluate the acceptability and efficacy of two brief, Internet-delivered cognitive behavioural therapy interventions—MUMentum Pregnancy (study 1) and MUMentum Postnatal (study 2)—in reducing maternal ...

    Authors: Siobhan A. Loughnan, Jill M. Newby, Hila Haskelberg, Alison Mahoney, Natalie Kladnitski, Jessica Smith, Emma Black, Christopher Holt, Jeannette Milgrom, Marie-Paule Austin and Gavin Andrews
    Citation: Trials 2018 19:56
  18. Most adults do not achieve the 150 minutes weekly of at least moderate intensity activity recommended for health. Adults’ most common physical activity (PA) is walking, light intensity if strolling, moderate i...

    Authors: Tess Harris, Sally M Kerry, Christina R Victor, Sunil M Shah, Steve Iliffe, Michael Ussher, Ulf Ekelund, Julia Fox-Rushby, Peter Whincup, Lee David, Debbie Brewin, Judith Ibison, Stephen DeWilde, Elizabeth Limb, Nana Anokye, Cheryl Furness…
    Citation: Trials 2013 14:418
  19. The Chinese government stipulates all food for special medical purposes (FSMP) designed for specific diseases to be tested in clinical trials before approving it for registration. The process of developing cor...

    Authors: Dongyu Mu, Jie Gong, Yaoyao Wei, Muxi Chen, Jiajie Yu, Liang Du and Wen Hu
    Citation: Trials 2023 24:223
  20. Up to 70% of adolescents with moderate to severe unipolar major depression respond to psychological treatment plus Fluoxetine (20-50 mg) with symptom reduction and improved social function reported by 24 weeks...

    Authors: Ian M Goodyer, Sonya Tsancheva, Sarah Byford, Bernadka Dubicka, Jonathan Hill, Raphael Kelvin, Shirley Reynolds, Christopher Roberts, Robert Senior, John Suckling, Paul Wilkinson, Mary Target and Peter Fonagy
    Citation: Trials 2011 12:175
  21. Australia has one of the highest rates of methamphetamine (MA) use in the world; however, uptake of in-person psychological treatment remains extremely low due to numerous individual (e.g. stigma, shame) and s...

    Authors: Dan I. Lubman, Victoria Manning, Shalini Arunogiri, Kate Hall, John Reynolds, Peta Stragalinos, Rachel Petukhova, Robyn Gerhard, Jonathan Tyler, Anna Bough, Anthony Harris and Jasmin Grigg
    Citation: Trials 2023 24:235
  22. The effectiveness of universal immunisation with pneumococcal conjugate vaccine (PCV) has been evident in many countries. However, the global impact of PCV is limited by its cost, which has prevented its intro...

    Authors: Grant A. Mackenzie, Arto A. Palmu, Jukka Jokinen, Isaac Osei, Stefan Flasche, Brian Greenwood, Kim Mulholland and Cattram Nguyen
    Citation: Trials 2022 23:1058
  23. Over the last few decades, effective psychological treatments for posttraumatic stress disorder (PTSD) have been developed, but many patients are currently unable to access these treatments. There is initial evid...

    Authors: Anke Ehlers, Jennifer Wild, Emma Warnock-Parkes, Nick Grey, Hannah Murray, Alice Kerr, Alexander Rozental, Esther T. Beierl, Apostolos Tsiachristas, Rafael Perera-Salazar, Gerhard Andersson and David M. Clark
    Citation: Trials 2020 21:355
  24. There is currently little evidence of planning for real-world implementation of physical activity interventions. We are undertaking the ComeBACK (Coaching and Exercise for Better Walking) study, a 3-arm hybrid...

    Authors: Siobhan Wong, Leanne Hassett, Harriet Koorts, Anne Grunseit, Allison Tong, Anne Tiedemann, Colin J. Greaves, Abby Haynes, Andrew Milat, Lisa A. Harvey, Nicholas F. Taylor, Rana S. Hinman, Marina De Barros Pinherio, Matthew Jennings, Daniel Treacy, Sandra O’Rourke…
    Citation: Trials 2022 23:40
  25. Given the rising number of strokes worldwide, and the large number of individuals left with disabilities after stroke, novel strategies to reduce disability, increase functions in the motor and the cognitive d...

    Authors: Agnes Flöel, Cordula Werner, Ulrike Grittner, Stefan Hesse, Michael Jöbges, Janet Knauss, Michael Seifert, Elisabeth Steinhagen-Thiessen, Mehmet Gövercin, Christian Dohle, Wolfgang Fischer, Regina Schlieder, Alexander Heinrich Nave, Andreas Meisel, Martin Ebinger and Ian Wellwood
    Citation: Trials 2014 15:45
  26. Medically unexplained symptoms (MUS) are highly prevalent and pose a burden both on patients and on health care. In a pilot study psychosomatic therapy delivered by specialised therapists for patients with MUS...

    Authors: Margreet S. H. Wortman, Johannes C. van der Wouden, Janneke P. C. Grutters, Bart Visser, Willem J. J. Assendelft, Henriëtte E. van der Horst and Tim C. olde Hartman
    Citation: Trials 2019 20:697
  27. Platform trials gained popularity during the last few years as they increase flexibility compared to multi-arm trials by allowing new experimental arms entering when the trial already started. Using a shared c...

    Authors: Marta Bofill Roig, Cora Burgwinkel, Ursula Garczarek, Franz Koenig, Martin Posch, Quynh Nguyen and Katharina Hees
    Citation: Trials 2023 24:408
  28. Recruiting patients to randomised controlled trials (RCTs) is often reported to be challenging, and the evidence base for effective interventions that could be used by staff (recruiters) undertaking recruitmen...

    Authors: Nicola Farrar, Daisy Elliott, Catherine Houghton, Marcus Jepson, Nicola Mills, Sangeetha Paramasivan, Lucy Plumb, Julia Wade, Bridget Young, Jenny L. Donovan and Leila Rooshenas
    Citation: Trials 2022 23:883
  29. Breathlessness is the most common and intrusive symptom of advanced non-malignant respiratory and cardiac conditions. The Breathlessness Intervention Service (BIS) is a multi-disciplinary complex intervention,...

    Authors: Morag C. Farquhar, A. Toby Prevost, Paul McCrone, Barbara Brafman-Price, Allison Bentley, Irene J. Higginson, Chris J. Todd and Sara Booth
    Citation: Trials 2016 17:185
  30. Early Intervention in Psychosis (EIP) services improve health outcomes for young people with psychosis in the medium–long term, but 25% of young people disengage in the first 12 months with costs to their ment...

    Authors: Kathryn Greenwood, Rebecca Webb, Jenny Gu, David Fowler, Richard de Visser, Stephen Bremner, Iga Abramowicz, Nicky Perry, Stuart Clark, Anastacia O’Donnell, Dan Charlton, Rebecca Jarvis, Philippa Garety, Sunil Nandha, Belinda Lennox, Louise Johns…
    Citation: Trials 2021 22:272

    The Update to this article has been published in Trials 2021 22:732

  31. Pneumococcal conjugate vaccines (PCV) effectively prevent pneumococcal disease but the global impact of pneumococcal vaccination is hampered by the cost of PCV. The relevance and feasibility of trials of reduc...

    Authors: Grant A. Mackenzie, Isaac Osei, Rasheed Salaudeen, Ilias Hossain, Benjamin Young, Ousman Secka, Umberto D’Alessandro, Arto A. Palmu, Jukka Jokinen, Jason Hinds, Stefan Flasche, Kim Mulholland, Cattram Nguyen and Brian Greenwood
    Citation: Trials 2022 23:71
  32. Women with stress urinary incontinence (SUI) experience urine leakage with physical activity. Currently, the interventional treatments for SUI are surgical, or endoscopic bulking injection(s). However, these p...

    Authors: L. Clark, B. Fitzgerald, S. Noble, S. MacNeill, S. Paramasivan, N. Cotterill, H. Hashim, S. Jha, P. Toozs-Hobson, T. Greenwell, N. Thiruchelvam, W. Agur, A. White, V. Garner, M. Cobos-Arrivabene, C. Clement…
    Citation: Trials 2022 23:628
  33. The evidence for the clinical utility of pharmacogenomic (PGx) testing is growing, and guidelines exist for the use of PGx testing to inform prescribing of 13 antidepressants. Although previous randomised cont...

    Authors: Sibel Saya, Patty Chondros, Anastasia Abela, Cathrine Mihalopolous, Mary Lou Chatterton, Jane Gunn, Timothy F. Chen, Thomas M. Polasek, Elise Dettmann, Rachel Brooks, Michelle King, Luke Spencer, Pavithran Alphonse, Shakira Milton, Georgia Ramsay, Zoe Siviour…
    Citation: Trials 2023 24:342
  34. In order to facilitate multinational clinical research, regulatory requirements need to become international and harmonised. The EU introduced the Directive 2001/20/EC in 2004, regulating investigational medic...

    Authors: Christian Gluud, Christine Kubiak, Kate Whitfield, Jane Byrne, Karl-Heinz Huemer, Steffen Thirstrup, Christian Libersa, Béatrice Barraud, Xina Grählert, Gabriele Dreier, Sebastian Geismann, Wolfgang Kuchinke, Zsuza Temesvari, Gyorgy Blasko, Gabriella Kardos, Timothy O'Brien…
    Citation: Trials 2012 13:27
  35. Meta-analyses of studies on psychological treatment of refugees describe highly varying outcomes, and research on multi-facetted and personalized treatment of refugees with post-traumatic stress disorder (PTSD...

    Authors: Bolette Daniels Beck, Steen Teis Lund, Ulf Søgaard, Erik Simonsen, Thomas Christian Tellier, Torben Oluf Cordtz, Gunnar Hellmund Laier and Torben Moe
    Citation: Trials 2018 19:301
  36. Juvenile dermatomyositis (JDM) is a rare autoimmune inflammatory disorder associated with significant morbidity and mortality. International collaboration is necessary to better understand the pathogenesis of ...

    Authors: Liza J. McCann, Jamie J. Kirkham, Lucy R. Wedderburn, Clarissa Pilkington, Adam M. Huber, Angelo Ravelli, Duncan Appelbe, Paula R. Williamson and Michael W. Beresford
    Citation: Trials 2015 16:268
  37. Enrolling participants in clinical trials can be challenging, especially with respect to prophylactic vaccine trials. The vaccination of study personnel in Ebola vaccine trials during the 2014–2016 epidemic pl...

    Authors: Edouard Lhomme, Camara Modet, Augustin Augier, Sylvain Faye, Tienhan Sandrine Dabakuyo-Yonli, Claire Levy-Marchal, Eric D’Ortenzio, Yazdan Yazdanpanah, Geneviève Chêne, Abdoul Habib Beavogui and Laura Richert
    Citation: Trials 2019 20:422
  38. Borderline personality disorder (BPD) is one of the most frequent, most debilitating and lethal mental conditions and is associated with a serious burden of disease. Treatment for patients with BPD involves st...

    Authors: Ueli Kramer, Loris Grandjean, Hélène Beuchat, Stéphane Kolly, Philippe Conus, Yves de Roten, Bogdan Draganski and Jean-Nicolas Despland
    Citation: Trials 2020 21:335
  39. The confidence with which researchers can comment on intervention efficacy relies on evaluation and consideration of intervention fidelity. Accordingly, there have been calls to increase the transparency with ...

    Authors: Alison Kate Beck, Amanda Baker, Ben Britton, Chris Wratten, Judith Bauer, Luke Wolfenden and Gregory Carter
    Citation: Trials 2015 16:465
  40. Studies have suggested that fluoxetine might improve neurological recovery after stroke, but the results remain inconclusive. The EFFECTS (Efficacy oF Fluoxetine – a randomisEd Controlled Trial in Stroke) reac...

    Authors: Erik Lundström, Eva Isaksson, Per Näsman, Per Wester, Björn Mårtensson, Bo Norrving, Håkan Wallén, Jörgen Borg, Martin Dennis, Gillian Mead, Graeme J. Hankey, Maree L. Hackett and Katharina S. Sunnerhagen
    Citation: Trials 2020 21:233

    The Correction to this article has been published in Trials 2020 21:388

    The original article was published in Trials 2015 16:369

  41. The aim of the RAAS-COVID-19 randomized control trial is to evaluate whether an upfront strategy of temporary discontinuation of renin angiotensin aldosterone system (RAAS) inhibition versus continuation of RA...

    Authors: Mona Aflaki, Alexandria Flannery, João Pedro Ferreira, Matthew Pellan Cheng, Nadine Kronfli, Ariane Marelli, Faiez Zannad, James Brophy, Jon Afillalo, Thao Huynh, Nadia Giannetti, Amal Bessissow, Justin A. Ezekowitz, Renato D. Lopes, Andrew P. Ambrosy, Morgan Craig…
    Citation: Trials 2021 22:115
  42. Amyotrophic lateral sclerosis (ALS) is a highly debilitating neurodegenerative condition. Despite recent advancements in understanding the molecular mechanisms underlying ALS, there have been no significant im...

    Authors: Flavia L. Lombardo, Stefania Spila Alegiani, Flavia Mayer, Marta Cipriani, Maria Lo Giudice, Albert Christian Ludolph, Christopher J. McDermott, Philippe Corcia, Philip Van Damme, Leonard H. Van den Berg, Orla Hardiman, Gabriele Nicolini, Nicola Vanacore, Brian Dickie, Alberto Albanese and Maria Puopolo
    Citation: Trials 2023 24:792
  43. Selective serotonin reuptake inhibitors (SSRIs) are commonly prescribed to manage anxiety in adults with an autism diagnosis. However, their effectiveness and adverse effect profile in the autistic population ...

    Authors: Dheeraj Rai, Doug Webb, Amanda Lewis, Leonora Cotton, Jade Eloise Norris, Regi Alexander, David S. Baldwin, Traolach Brugha, Madeleine Cochrane, Maria Chiara Del Piccolo, Emma J. Glasson, Katherine K. Hatch, David Kessler, Peter E. Langdon, Helen Leonard, Stephanie J. MacNeill…
    Citation: Trials 2024 25:37
  44. Children of parents with mental illness have an increased risk of developing mental illness themselves throughout their lifespan. This is due to genetic factors but also environmental disadvantages during chil...

    Authors: Signe S. Nielsen, Lisbeth J. Mikkelsen, Nikolaj Quaade, Tracy R. G. Gladstone, William R. Beardslee, Katrina Bonnemose, Nicole K. Rosenberg, Carsten Hjorthøj, Anne A. E. Thorup, Merete Nordentoft and Anne Ranning
    Citation: Trials 2023 24:291
  45. Major depressive disorder is a leading cause of disease burden worldwide, indicating the importance of effective therapies. Outcome studies have shown overall efficacy of different types of psychotherapy acros...

    Authors: Reitske Meganck, Mattias Desmet, Claudi Bockting, Ruth Inslegers, Femke Truijens, Melissa De Smet, Rosa De Geest, Kimberly Van Nieuwenhove, Vicky Hennissen, Goedele Hermans, Tom Loeys, Ufuoma Angelica Norman, Chris Baeken and Stijn Vanheule
    Citation: Trials 2017 18:126
  46. Randomised controlled trials (RCTs) that fail to meet their recruitment target risk increasing research waste. Acute stroke RCTs experience notable recruitment issues. The efficiency of recruitment to stroke r...

    Authors: Kris McGill, Catherine M. Sackley, Jon Godwin, Jodie McGarry and Marian C. Brady
    Citation: Trials 2020 21:68

Annual Journal Metrics

  • 2022 Citation Impact
    2.5 - 2-year Impact Factor
    2.5 - 5-year Impact Factor
    0.827 - SNIP (Source Normalized Impact per Paper)
    0.814 - SJR (SCImago Journal Rank)

    2023 Speed
    33 days submission to first editorial decision for all manuscripts (Median)
    129 days submission to accept (Median)

    2023 Usage 
    6,282,238 downloads
    5,569 Altmetric mentions